Clinical Trial Update: Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine [NA]

View source ↗

Summary

This ClinicalTrials.gov update shows a completed study on melatonin metabolism abnormalities in patients with schizophrenia or schizoaffective disorder treated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Seattle Institute for Biomedical and Clinical Research | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2024-12-05